IDT ASX · Health Care

IDT Australia Ltd

Announcements, last 12 months
33
Price sensitive, last 12 months
6
Followed on InvestorPA
Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released Headline Actions
Proposed issue of securities - IDT
Notification regarding unquoted securities - IDT
Notice of Annual General Meeting and Proxy Form
Change in substantial holding
Cleansing Notice
Application for quotation of securities - IDT
Notification regarding unquoted securities - IDT
Application for quotation of securities - IDT
Change of Director's Interest Notice - GS
FY26 Full Year Results Presentation

Sign in to see all IDT announcements.

Guidance history

20 Aug 2026 EBITDA improved by over 85%, revenue from core verticals grew by 16.5%
21 Jul 2026 IDT Australia Ltd expects FY26 revenue of $16.8M and EBITDA of -$943K
28 Apr 2026 IDT is forecasting FY26 operating revenue from its three verticals to increase to between $15 million and $16 million (+4% to +11%), while EBITDA losses are expected to narrow to between $1.5 million and $2 million (vs. FY25 EBITDA loss of $6.3 million).

Sign in to see the full guidance history.

Most followed in Health Care

  • PME Pro Medicus Ltd
  • AHC Austco Healthcare Ltd
  • CSL CSL Ltd
  • RMD Resmed Inc
  • TLX TELIX Pharmaceuticals Ltd
  • CGS Cogstate Ltd
  • ALC Alcidion Group Ltd
  • CSX Cleanspace Holdings Ltd
Follow IDT to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in